Showing results (601-610 of 944) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|March 23, 2019
Polypharmacy in an Elderly Population: Enhancing Medication Management Through the Use of Clinical Decision Support Software PlatformsDorothy Keine, Mark Zelek, John Q Walker, et al.
Neurology and Therapy|March 28, 2019
PatientConcept App: Key Characteristics, Implementation, and its Potential BenefitMichael Lang, Martin Mayr, Stefan Ringbauer, et al.
Neurology and Therapy|October 27, 2018
Phase 1 Parkinson's Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well ToleratedU Shivraj Sohur, David L Gray, Sridhar Duvvuri, et al.
Neurology and Therapy|March 9, 2019
Risperdal® CONSTA® Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans AffairsMarsha A Wilcox, Danielle Coppola, Nicole Bailey, et al.
Neurology and Therapy|March 10, 2023
Podcast on the Art of the Patient Conversation: Healthcare Provider Perspectives to Improve Outcomes in Multiple SclerosisCortnee Roman, Denise Bruen
Neurology and Therapy|February 14, 2023
Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel TreatmentHongxia Yang, Guoyan Qi, Huimin Dong, et al.
Neurology and Therapy|March 18, 2023
Clinical and Scientific Challenges to Effectiveness Studies Under Coverage with Evidence Development in Alzheimer's DiseasePeter J Morin, Quanwu Zhang, Weiming Xia, et al.
Neurology and Therapy|April 17, 2021
Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson's Disease and DyskinesiaShyamal H Mehta, Rajesh Pahwa, Caroline M Tanner, et al.
Neurology and Therapy|February 1, 2026
Patient Experiences with Relapsing-Remitting and Primary Progressive Multiple Sclerosis: Development of a Conceptual Model to Inform Clinical Outcome Assessment EvaluationEkin Seçinti, Louise Barrett, Laure Delbecque, et al.
Neurology and Therapy|February 8, 2026
Efgartigimod as an Add-on Therapy for Anti-IgLON5 Disease: A Case ReportZheng Wang, Zi-Yang Huang, Lin Liu, et al.
Pageof 95